TEAM Form 144: 490,560 Shares Proposed Sale Valued $84.7M
Atlassian Corporation (TEAM) Form 144 notice: A holder intends to sell 490,560 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $84,719,712 and an approximate sale date of 09/09/2025 on NASDAQ.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Atlassian Corporation (TEAM) Form 144 notice: A holder intends to sell 490,560 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $84,719,712 and an approximate sale date of 09/09/2025 on NASDAQ. The shares were acquired as founders shares on 07/02/2010. The filing also lists a series of prior 10b5-1 sales executed by "Farquhar Investment Partnership 2" on many dates between 06/10/2025 and 09/08/2025, each for 7,665 shares with reported gross proceeds per trade. The notice includes the required representation about absence of undisclosed material adverse information and references a trading plan/10b5-1 program where applicable.
Positive
- Compliance with Rule 144 is documented, including broker details and representation about material information
- Use of 10b5-1 plans for prior sales indicates systematic, prearranged disposition rather than opportunistic trading
Negative
- Large proposed sale of 490,560 shares with an aggregate market value of $84,719,712 may increase share supply
- Ongoing significant selling activity by Farquhar Investment Partnership 2 shown across many dates could be perceived negatively by the market
Insights
TL;DR: Large scheduled sale announced; multiple prior 10b5-1 transactions show ongoing systematic disposition.
The filing discloses a proposed sale of 490,560 shares valued at $84,719,712, scheduled for 09/09/2025, executed via Morgan Stanley Smith Barney. The shares were originally held as founders shares acquired on 07/02/2010. The document also enumerates numerous prior 10b5-1 sales by Farquhar Investment Partnership 2 of 7,665 shares each across many dates from June to early September 2025, with varying gross proceeds reported per trade. From a market perspective, a single large notice of sale and repeated daily 10b5-1 dispositions can increase supply pressure and may affect intraday liquidity, but the filing itself is a routine disclosure of intended and prior sales rather than an operational or financial disclosure about the issuer.
TL;DR: The filing documents compliance with Rule 144 and reliance on 10b5-1 plans, but signals significant insider/affiliate selling.
The notice indicates the seller holds founders shares acquired in 2010 and is using established broker execution and 10b5-1 programs for systematic sales. The repeated 10b5-1 entries and the current Form 144 suggest structured disposition rather than ad hoc sales, which supports procedural compliance. However, the size of the proposed sale (490,560 shares) is material in absolute terms and warrants attention from governance stakeholders for potential impacts on shareholder composition and perceived insider confidence. The filing contains the required legal representation about material adverse information and does not assert any undisclosed facts.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is the size and value of the proposed sale in the TEAM Form 144?
Who is executing the proposed sale and on which exchange for TEAM?
Does the Form 144 include a representation about undisclosed material information?
AI-generated analysis. How Rhea-AI works. Not financial advice.